
Highlights from the Prechter Bipolar Disorder Learning Community
The Prechter Bipolar Disorder Learning Community Celebrates Two Years!
The Prechter Bipolar Disorder Learning Community Celebrates Two Years!
Leah has joined the Prechter Program as the Associate Director of Development, Mental Health Programs.
The Brain and Behavior Research Foundation selected research from the Prechter Program for the Foundation's 2024 Leading Research Achievements.
Dr. Sperry is a recipient for a 2024 American College of Neuropsychopharmacology (ACNP) senior level travel award.
The lab and research staff will be out of the office from 12/21/24-1/2/25.
Provide your feedback about Prechter Program events.
A new study published in the Journal of Psychiatric Research reveals a critical link between sleep disturbances and suicide risk in individuals with bipolar disorder.
The University of Michigan Department of Psychiatry is hosting a webinar on Ketamine for mental health treatment on December 5th.
New research from the Bipolar Research in Sleep and Circadian Rhythms Collaborative (BRSCr) looks at mood fluctuations during the season changes.
The Prechter Program could not study bipolar disorder without the help of those participants — including Kiersten.
BBRF shines a light on recent research from the Prechter Program that uses 'Mood Instability' measures to best assess care for bipolar disorder.
In case you missed General Gregg F. Martin, Ph.D. at the Prechter Lecture, watch the recording today!
Learn more about the Prechter Bipolar Disorder Learning Community and the new Wellness Measure.
Monitoring fluctuations in emotion, mood, and functioning through changes in speech.
A new study in collaboration between the Prechter Program and the Sleep and Circadian Research Lab, "Light Sensitivity in Bipolar Disorder: A Potential Driver of Variability in Sleep, Mood and Energy."
From Ann Arbor to Reykjavik: Prechter Program travels across the globe for the 2024 ISBD Conference.
Download this year's Prechter Program Newsletter and Impact Report
Prechter Program faculty and collaborators revisit research on lithium and COVID-19.
Reducing variation in symptoms over time, not just capturing mood episodes, should be the goal for treatment and clinical trials, long term analysis suggests.
Study shows even temporary increases in drinking can lead to long-lasting changes in symptoms, but not vice versa; effect happens even below problematic levels of alcohol use.